ROS1 and fibrosis: There were no significant differences in smoking history, histologic type, clinical stage, lymphangitis, lymphadenopathy, fibrosis, and pleural effusion between the ALK&ROS1‐negative group and the ALK&ROS1‐positive group (Table 3).